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Our objective was to assess the antioxidant properties and the effects against the reperfusion injury of a nonalcoholic extract
obtained by fermentation from the Colombian blueberry, mortin˜o (Vaccinium meridionale Swartz, Ericaceae). Antioxidant
properties were assessed by in vitro systems. To examine the postischemic myocardial function, isolated rat hearts were treated
10min before ischemia and during the first 10min of reperfusion with the extract. To analyze the participation of nitric oxide
(NO), other experiments were performed in the presence of nitric oxide synthase (NOS) inhibition with NG-nitro-L-arginine
methyl ester (L-NAME). In cardiac tissue thiobarbituric acid reactive substances (TBARS) concentration, reduced glutathione
(GSH) content, endothelial NOS (eNOS), and Akt expression were also measured. The blueberry extract showed higher total
phenols and anthocyanins contents, scavenging activity of superoxide radical and systolic and diastolic function was improved,
TBARS diminished, GSH was partially preserved, and both NOS and Akt expression increased in hearts treated with the extract.
These beneficial effects were lost when eNOS was inhibited. In resume, these data show that the increase of eNOS expression via
Akt and the scavenging activity contribute to the cardioprotection afforded by acute treatment with Colombian blueberry extract
against ischemia and reperfusion injury.
1. Introduction
Oxidative stress is defined as the imbalance between the
generation of reactive oxygen species (ROS) and antioxi-
dant defense mechanisms. Myocardial damage induced by
ischemia-reperfusion of the heart has been proposed to be
caused, at least in part, by ROS production [1–3]. Indirect
evidence supporting this hypothesis has been the cardiopro-
tective effects of ROS scavengers and agents capable of induc-
ing antioxidants such as glutathione peroxidase (GSHpx)
and superoxide dismutase (SOD) and of supplementing
antioxidants [4].The detrimental action of ROS has naturally
led to increased interest in antioxidants, in particular, plant
diet-derived antioxidants, as possible therapeutic agents [5,
6]. Unfortunately, the attempts to use synthetic antioxidants
to block or attenuate the harmful effects of ROS have
produced mixed and mostly negative results [7, 8]. There
are various elements involved in this “antioxidant paradox,”
such as the selection of dose, degree of collateral blood
flow, duration of ischemia, timing of drug administration,
and drug delivery method [9]. Reduced nitric oxide (NO)
bioavailability is other important factor mediating ischemia
and reperfusion injury [10]. Thus, the treatment with NO
donors is able to prevent reperfusion-induced cell death
2 Evidence-Based Complementary and Alternative Medicine
[11]. Data from our group [12] and other laboratories [13]
show that NO mediates the beneficial effects of natural
antioxidants.
The polyphenols present in fruits, green tea, “yerbamate,”
black chocolate, or red wine exert antioxidant properties
through various mechanisms of action including the ROS
scavenging and ROS generation inhibition, thereby prevent-
ing damage to lipids, proteins, nucleic acids, and eventually
cell damage and death [14]. These properties appear involved
in the beneficial effects of those natural products on health
previously reported by us [12, 15–17] and other researchers
[18, 19]. The genus Vaccinium provides a group of plants
with promising antioxidant properties. It includes about 400
species, which grow principally in the hillside of tropical
mountains. One of them, agraz or Colombian blueberry, is
the species Vaccinium meridionale Swartz (Ericaceae) which
grows in the Andean region of South America at 2300–
3300m and it is a wild bush of 1–4m high, sometimes until
8m. The fruits are edible dark purple berries [20]. It is
currently available only in the wild and their spontaneous
populations are found across the Colombian mountains [21].
Blueberries contain phenolics such as anthocyanins and
flavonoids and appear to have the highest antioxidant capac-
ity among fruits and vegetables [22, 23], and the fermented
juice, such as in the case of wine, improves its processing
and storage effects on anthocyanin composition, color, and
appearance [24].Thus, consumption of berries or their related
products could be of importance not only in themaintenance
of health [25, 26] but also in the preventing of cardiovascular
disease. Thus, Ahmet et al. [27] showed that a blueberry-
enriched diet increased myocardial tolerance to ischemic
damage in a rat model of postmyocardial infarction dilated
cardiomyopathy.
Therefore, the objective of the current study was to assess
the antioxidant properties and the effects against reperfusion
injury in the isolated rat heart of a fermented nonalcoholic
extract of Colombian blueberry, examining the role played by
NO.
2. Materials and Methods
2.1. Plant Material. Vaccinium meridionale constitutes the
raw material used for the fermentation in this research;
berries fruits were harvested at the beginning of Decem-
ber 2009, in Colombia, zone “El Retiro” (2175m.a.s.l) into
Antioquia region. The plant and berries were identified by
the Corporacio´n Colombiana de Investigacio´n Agropecuaria
(Corpoica), La Selva, Colombia (voucher specimen number
ILS 14050070). The berries were manually harvested at
the commercially appropriate ripeness stage (fruit maturity
was based on fruit surface color) and transported to the
Laboratory of Food Science, Faculty of Sciences, National
University of Colombia in hermetic plastic canisters. In this
place, the berries were cleaned by removing leaves, stems, and
unripe and damaged berries.
2.2. Blueberries Processing. The maceration was performed
in the traditional fashion, punching the berries fruits (2 kg)
several times at −18∘C during 2 days. After prefermentative
cold maceration, H
2
O purified (2 L) was added.
2.3. Fermentation Experiment. The berry juice was trans-
ferred into stainless steel tank (5 L, 320 × 144 × 2mm),
and the fermentation was carried out by the inoculation of
0.165 g/L of selected cultures of yeast Saccharomyces cerevisiae
Meyen ex E.C.Hansen 1883 (ARSCultureCollection,USDA).
The fermentation was performed at 25 ± 2∘C for 10 days.
The soluble solids were adjusted to 30 ∘Brix with sugar. The
fermentation was stopped by the addition of 40mg SO
2
/L.
Then, the fermented berry productwas decanted, treatedwith
albumin (0.4 g/L), and filtered through filter plates (45𝜇m).
2.4. Standard Chemical Analysis. The total titratable acidity
was assessed by titration with sodium hydroxide (0.1 N)
and expressed as tartaric acid. The pH value was measured
using a digital pH meter (Hanna Instruments, Buenos Aires,
Argentina). Total soluble solids (∘Brix) were measured as
Brix using a refractometer RX-5000 (Atago, Tokyo, Japan).
The alcoholic title was quantified as ethanol by GC-FID,
using an Agilent 6890NGC system (Ramsey, MN, USA).The
values of these parameters at the beginning and at the end of
fermentation process are showed in Table 1. HPLC analysis
was carried out using a column Zorbax C18 (250 × 4.6mm,
5 𝜇mparticle size), oven temperature 38∘C.The solvents used
were acetonitrile/formic acid/water (3 : 10 : 87) as solvent A
and acetonitrile/formic acid/water (50 : 10 : 40) as solvent B.
The elution gradient was as follows: 0min 94% A and 6% B;
10min 80% A and 20% B; 20min 60% A and 40% B; 30min
50% A and 50% B; 35min 94% A and 6% B.The flow rate was
0.8mL/min. Detection was measured at 525 nm. All analyses
were made in triplicate.
2.5. Preparation of the Nonalcoholic Extract (BE). The extract
of berries fermented (200mL) was vacuum-evaporated
(<30∘C). The berry juice (BJ) was used as control. After
being filtered, the aqueous extract was lyophilized and dry
matter was maintained at −20∘C until used.The nonalcoholic
extract was chromatographed by HPLC and a representative
chromatogram is included in Figure 1. The solid residue
was 0.04 and 0.18 g/mL for BE and BJ, respectively. The
residues were solubilized in deionized or Ringer’s solution
immediately before the assays.
2.6. Determination of Total Phenols and Total Anthocyanins
Contents. Total phenolic content was measured by using
the Folin-Ciocalteu. Results were expressed as caffeic acid
equivalents/mg of dry weight of the extract [28]. Total
anthocyanins were determined by using a pH differential
method [29]. Results were expressed as mg of cyanidin-3-
glucoside equivalents/mg of dry weight of the extract.
2.7. Total Antioxidant Activity
2.7.1. 1,1-Diphenyl-2-picryl-hydrazyl (DPPH) Scavenging
Activity. Reduction of the stable free radical DPPH was
determined with the aid of a modified version of the method
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Figure 1: Anthocyanins profile. HPLC-UV chromatograms of fermented blueberry, (a) corresponds to the anthocyanins profile at the
beginning of the fermentation process and (b) corresponds to the anthocyanins profile at the end of the fermentation process. Peak
identification: 1, Delphinidin 3-glucoside; 2, cyanidin-3-glucoside; 3, petunidin-3-glucoside. Chromatographic analysis was carried out using
a column Zorbax C18 and mixtures of acetonitrile/formic acid/water as mobile phase. The flow rate was 0.8mL/min and detection was
measured at 525 nm.
Table 1: Physicochemical characteristics of berry process fermenta-
tion.
Days 1 10
Treatment BE BE
Ethanol %(a) 0.20 11.05
pH 2.58 2.82
∘Brix 30 6.2
Total titratable acidity(b) 7.01 8.89
(a)
Expressed as alcoholic title% w/v; (b)Expressed as g/L of tartaric acid. BE:
berry extract.
described by Cavin et al. [30]. The results are expressed in 𝜇g
caffeic acid equivalents/mg of dry weight of the extract.
2.7.2. 2,2󸀠-Azino-bis(3-ethylbenzothiazoline-6-sulphonic Acid
(ABTS)∙+ Scavenging Activity. Reduction of the stable ABTS
radical cation was determined with the aid of a modified
version of the method described by Re et al. [31]. Results are
expressed as caffeic acid equivalents/mg of dry weight of the
extract.
2.7.3. Ferric Reducing Antioxidant Power (FRAP). The FRAP
assay was carried out to determine the reducing ability
of the extracts with a method adapted from Benzie and
Strain [32]. Results were expressed as 𝜇mol of ascorbic acid
equivalents/mg of dry weight of the extract.
2.8. Scavenging Activities
2.8.1. Scavenging of Superoxide Anion (O
2
∙−
). O2∙− was gen-
erated through enzymatic oxidation of hypoxanthine with
xanthine oxidase grade I (0.06U) and was detected by
the reduction of nitroblue-tetrazolium (NBT), monitored
spectrophotometrically at 560 nm. Details of this assay have
been described elsewhere [17]. Allopurinol was used as a
reference.
2.8.2. Scavenging of Peroxynitrite Anion (ONOO−). ONOO−
was synthesized in a quenched flow reactor in accordance
with the method described by Koppenol et al. [33]. The
pyrogallol red bleaching assay was carried out as reported by
Balavoine and Geletii [34].
2.8.3. Nitration of Blood Serum Albumin (BSA) Induced by
ONOO−. Reaction between ONOO− and BSA was carried
out as described by Jiao et al. [35]. Samples of control, BE, and
BJ were analyzed by SDS-polyacrylamide gel electrophoresis
(SDS-PAGE, 10%) following the Laemmli method by staining
with Coomasie blue. The nitration of BSA was examined
by the Western blot using an antinitrotyrosine polyclonal
antibody (Cayman Chemicals, Ann Arbor, MI, USA). The
bands were visualized with an ECL-Plus chemiluminescence
detection system and analyzed by densitometric analysis
using Scion Image software (ScionCo., Frederick,MD,USA).
2.8.4. Hydroxyl Radical (OH∙) Scavenging Assay. The OH∙
scavenging assay was carried out according to the method
described by Schinella et al. [17]. This assay was performed
in triplicate with DMSO (20mM) as a reference.
2.9. Isolated Heart Preparation. All procedures followed dur-
ing this investigation conform to the Guide for the Care and
Use of Laboratory Animals published by the US National
Institutes of Health (NIH Publication No. 85–23, revised
1996) and to the guidelines laid down by the Animal Welfare
Committee of La Plata School of Medicine. Male Wistar rats
of 5-6 months of age were anesthetized with an intraperi-
toneal injection of sodium pentobarbital (60mg/kg body
wt). The heart was excised and perfused through the aorta
by the nonrecirculating Langendorff technique with Ringer’s
solution (pH 7.4) and at 37∘C. Heart rate was maintained
at 280 ± 10 beats/min. A latex balloon was placed inside
the left ventricle (LV) and connected to a Statham P23XL
pressure transducer. The balloon was filled with water to
provide an end-diastolic pressure (LVEDP) of 8–12mmHg,
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and this volumewas unchanged for the rest of the experiment.
Coronary perfusion pressure was adjusted to approximately
60–70mmHg and coronary flow was 11 ± 2mL/min. Left
ventricular pressure (LVP) was acquired by using an analog-
to-digital converter and acquisition software (Chart V4.2.3
AD Instruments Sudame´rica, Santiago de Chile, Chile).
2.9.1. Experimental Protocols. After 10min of stabiliza-
tion, the following experimental protocols were performed.
Ischemic control (IC) hearts (𝑛 = 6): hearts were subjected to
20min of normothermic global ischemia followed by 30min
of reperfusion. Global ischemia was induced by stopping the
perfusate inflow line and the heart was placed in a saline bath
held at 37∘C. Hearts treated with BE and BJ (𝑛 = 6 for each
treatment): hearts were treated 10min before ischemia and
the initial 10min of reperfusion with the blueberry extract
(50𝜇g/mL).The administration time was selected taking into
account that reperfusion injury is the result of alterations that
occur during ischemia and the first minutes of reperfusion
[16]. Other hearts (𝑛 = 4) received 1mM of NG-nitro-
L-arginine methyl ester (L-NAME), a nonselective NOS
inhibitor, 20min before ischemia and during the reperfusion
period. The L-NAME administration was extended through
the entire reperfusion time to prevent the activation of the
different NOS isoforms.
2.9.2. Systolic and Diastolic Function. Myocardial contrac-
tility was assessed through the left ventricular developed
pressure (LVDP), obtained by subtracting LVEDP to the LVP
peak values and the maximal rise velocity of the left ventricu-
lar pressure (+𝑑𝑃/𝑑𝑡max). Data were expressed as percentages
of their respective preischemic values. The diastolic function
was evaluated through the isovolumic LVEDP.
2.10. BiochemicalDeterminations from IsolatedHeart Prepara-
tion. At the end of reperfusion, hearts were frozen in liquid
N
2
and kept at −70∘C until the moment of assays.
2.10.1. Assessment of Lipid Peroxidation. A portion of LV was
homogenized in a solution composed by 25mM KH
2
PO
4
-
140mM KCl at pH = 7.4 with a Polytron homogenizer. The
samples were centrifuged and in the supernatant, an index of
lipid peroxidation TBARSwas determined by a spectroscopic
technique and expressed as nmol MDA/g tissue weight [36].
2.10.2. Reduced Glutathione (GSH). Aliquots of homogenate
were used to assess reduced glutathione content (GSH)
according to Ellman’s method [37] and expressed as nmol
GSH/g tissue weight.
2.10.3. Western Blot Analysis. Other portion of LV was
homogenized in ice-cold RIPA buffer (300mM sucrose,
1mM DTT, 4mM EGTA, 20mM Tris pH 7.4, 1% Triton X,
10% protease cocktail, 25 𝜇M NaF, and 1 𝜇M orthovanadate),
centrifuged at 10000×g for 15min at 4∘C. The supernatant
was collected and subjected to SDS-PAGE.The samples were
transferred to a PVDFmembrane (2 h). Equal loading of sam-
ples was confirmed by Ponceau S staining. Membranes were
blocked with 5% nonfat milk in Tris-buffered saline (pH 7.5)
containing 0.1% Tween (TBS-T) and probed overnight at 4∘C
with antibodies anti-eNOS (Sigma-Aldrich, St. Louis, MO,
USA), anti-Akt (Calbiochem, Merck Millipore Darmstadt,
Germany). Membranes were washed four times for 10min in
TBS-T prior to the addition of anti-rabbit secondary antibody
(1 : 1000 dilution) and the antibody-antigen complexes were
developed using a chemiluminescent system (ECL Plus; GE
Healthcare, Buckinghamshire, UK).
2.11. Statistical Analysis. Data were expressed as means ± SE.
Statistical analysis was performed by one-way analysis of vari-
ance (ANOVA) followed by Student-Newman-Keulsmultiple
comparisons test. Differences were considered significant at
𝑃 < 0.05.
3. Results
3.1. Antioxidant Activity. The total antioxidant activity was
measured through the ability of the extracts to reduce
DPPH∙ ABTS∙+ and Fe3+- and the content of total phenols
and anthocyanins of BE was higher than BJ. BE also showed a
higher O
2
∙− and ONOO− scavenging activity in comparison
to BJ (Table 2). Moreover, it was detected as an attenuation
of BSA degradation (Figure 2(a)) and nitration (Figure 2(b))
in the presence of BE. As indicated by graphic bar BE and
BJ significantly decreased the percentage of nitrotyrosine
compared to control (Figure 2(b)). However, the change
produced by BJ was lesser to that obtained by BE. At a final
concentration of 100𝜇g/mL, none of the extracts were able
to scavenge the OH∙ produced in the Fe3+-EDTA + H
2
O
2
system in the presence or the absence of ascorbate. Moreover,
the results showed a significant increase of deoxyribose
degradation after the treatment with the two samples in the
absence of ascorbate (data not shown).
3.2. Myocardial Systolic and Diastolic Function and Oxidative
Damage of Cardiac Tissue. After BE treatment the postis-
chemic recovery improved, reaching LVDP values signifi-
cantly higher than that obtained in IC hearts (87 ± 8% versus
42 ± 3% at the end of reperfusion period). The treatment
with BJ did not modify the postischemic recovery detected
in IC hearts and at the end of reperfusion LVDP reached
a value of 39 ± 9% (Figure 3(a)). A similar pattern was
obtained when +𝑑𝑃/𝑑𝑡max was analyzed (Figure 3(b)). The
ischemic contracture observed in IC hearts was not modified
after all the treatments applied. The treatment with BE but
not with BJ was able to attenuate the increase of LVEDP
detected during reperfusion in IChearts (18± 6mmHgversus
49 ± 6mmHg at the end of reperfusion period) (Figure 3(c)).
The NOS inhibition with L-NAME abolished the protective
effect of BE on postischemic recovery of systolic myocardial
function (Figure 4). In addition, LVEDP was impaired after
the combination of BE + L-NAME reaching a value of 59 ±
14mmHg at the end of the reperfusion period.
TBARS content (Figure 5(a)) diminished and GSH level
(Figure 5(b)) was partially preserved when hearts were
treated with BE but not after BJ compared with untreated
hearts. These beneficial effects were annulled in presence of
NOS inhibition detecting an increase of lipid peroxidation
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Table 2: Phenolics compounds, total antioxidant activity, and reactive oxygen species (ROS) scavenging properties of fermented berry extract
(BE) and berry juice (BJ).
Sample Phenolic compounds Antioxidant activity ROS scavenging
Total phenolics(a) Total anthocyanins(c) DPPH(a) ABTS∙+(a) FRAP(b) O
2
∙−(a) ONOO−(b)
BE 49 34 23 73 220 5.6 5.0
BJ 18 12 5 24 72 2.3 1.3
(a)
Results are expressed as caffeic acid equivalent (𝜇g/mg dry weight of extract); (b)results are expressed as ascorbic acid equivalent (𝜇mol/mg dry weight of
extract); (c)results are expressed as cyanidin-3-glucoside equivalents (𝜇mol/mg dry weight of extract).
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Figure 2: (a) Degradation; (b) nitration of BSA induced byONOO−. Both extracts attenuated the degradation and nitration of BSA compared
to control. However, the effects of fermented berry extract (BE) were significantly higher than that of berry juice (BJ). ∗𝑃 < 0.05 with respect
to control; #𝑃 < 0.05 with respect to BE.
and less GSH level (Figures 5(a) and 5(b): BE + L-NAME
column).
The treatment with BE increased the expression of eNOS
compared to that detected in IC hearts while BJ treatment
decreased it (Figure 6(a)). When BE was administered in
the presence of NOS inhibitor L-NAME, eNOS expression
decreased to levels significantly lesser than those of IC. The
expression of p-Akt (Figure 6(b)) showed the same changes
except in the BJ group in which the p-Akt expression was not
different to IC hearts.
4. Discussion
The present study provides evidence about the antioxidant
properties and cardioprotective effects of a nonalcoholic
extract of fermented Colombian blueberry in isolated rat
heart. This fermented extract showed higher antioxidant
capacity (Figure 2 andTable 2) in comparison to BJ attributed
to their higher content of total phenols and anthocyanins.
It also detected a different composition of polyphenols
(Figure 1) in BE in comparison to BJ.
In isolated rat hearts, the treatment with BE improved
the postischemic recovery of systolic and diastolicmyocardial
function.Therefore, an increase of contractility parameters as
left ventricular developed pressure (Figure 3(a)) and themax-
imal rise velocity of the left ventricular pressure (+𝑑𝑃/𝑑𝑡max,
Figure 3(b)) were detected in treated hearts when the coro-
nary flow was restored. Simultaneously, a decrease of left
ventricular end-diastolic pressurewas observed during reper-
fusion in hearts treated with BE indicating that myocardial
diastolic stiffness was minor in the presence of the extract
(Figure 3(c)). The figure also shows that the treatment with
BJ did not improve the postischemic recovery of myocardial
function displaying the absence of beneficial effects in our
experimental conditions.
Which are the mechanisms involved in the cardioprotec-
tive action of BE? The NO derived principally of the consti-
tutive endothelial nitric oxidase synthase (eNOS) is able to
exert beneficial or deleterious effects.Thus, NO interacts with
proteins via S-nitrosylation at specific cysteine residues to
alter their function [38, 39] which has an important meaning
regarding the excitation-contraction (EC)-coupling-related
process [38]. In the normal range of O
2
∙−, S-nitrosylation
is accommodated; however, it is inhibited when O
2
∙− is
increased [40]. As noted, increasedO
2
∙− interacts with NO to
form ONOO−, a reactive species that is capable of triggering
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Figure 3: (a) Time course of left ventricular developed pressure (LVDP); (b) maximal rise velocity of left ventricular pressure (+𝑑𝑃/𝑑𝑡max);
left ventricular end-diastolic pressure (LVEDP) during ischemia and reperfusion in ischemic control hearts (IC, 𝑛 = 6) and in hearts treated
with the fermented berry extract (BE, 𝑛 = 6) and berry juice (BJ, 𝑛 = 6). Note that LVDP and +𝑑𝑃/𝑑𝑡max increased and LVEDP decreased
during reperfusion only after treatment with BE. ∗𝑃 < 0.05 with respect to IC.
an array of cytotoxic processes, including lipid peroxidation,
protein oxidation, and nitration (altering EC coupling) [41,
42]. In our experiments, the eNOS inhibition abolished the
cardioprotective effects afforded by BE. Thus, an impairment
of systolic and diastolic myocardial function was evident in
the presence of L-NAME (Figure 4) indicating that NO plays
a crucial role in the attenuation of contractile dysfunction that
follows the ischemia and the reperfusion.
On the other hand, it is well known that brief episodes
of myocardial ischemia and reperfusion are associated with
the generation of ROS [1–3, 43]. ROS cause lipid peroxidation
first leading to reversible damage and eventually to necrosis
and/or apoptosis. The administration of antioxidants or free
radicals scavengers is able to limit the evolution ofmyocardial
damage reducing ROS-induced lipid peroxidation [44]. In
this study, we found that TBARS decreased and the level of
GSH was higher in hearts treated with BE in comparison to
ischemic control hearts displaying an attenuation of oxidative
stress by the extract. However, lipid peroxidation increased
and GSH levels decreased in hearts treated with L-NAME,
showing the predominance of ROS and the consequent
oxidative damagewhen eNOSwas inhibited (Figures 5(a) and
5(b)). Western blot analysis revealed that eNOS expression
of hearts treated with BE increased compared to untreated
hearts and this effect was annulled by eNOS inhibition
(Figure 6(a)). Which can be the pathway of eNOS activation
by BE? As shown in Figure 6(b), the level of Akt phos-
phorylation also increased in hearts treated with BE, effect
that was abolished by eNOS inhibition. Taking into account
that phosphatidylinositol-3-kinase- (PI3K-) Akt can activate
eNOS [45], our data suggest that Akt is involved in the
activation of eNOS mediated by BE.
Because TBARS decrease coincides with higher eNOS
expression level and that L-NAME treatment prevented these
changes, it might at first be assumed that eNOS-derived
NO could be involved in the attenuation of oxidative stress
that occurs during ischemia and reperfusion. In fact, a
close relationship between NO and oxidative stress has long
been proposed [46]. Moreover, data from Clancy et al. [47]
indicate that NO reacts with intracellular GSH forming
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Figure 5: (a) Effects of fermented berry extract (BE, 𝑛 = 6) and berry juice (BJ, 𝑛 = 6) and BE + L-NAME (𝑛 = 4) on lipid peroxidation
(MDA); (b) reduced glutathione (GSH). The treatment with BE attenuated lipid peroxidation and preserved GSH levels in comparison to IC
hearts.These favorable changes were annulled when BE was administered in the presence of NOS inhibitor, L-NAME. ∗𝑃 < 0.05with respect
to IC; #𝑃 < 0.05 with respect to BE.
S-nitrosoglutathione, compound which may function as sta-
ble intermediate of NO activity. Therefore, the improvement
of GSH level added to the in vitro demonstration of the
capacity of the extract to remove O
2
∙− and ONOO− could
be indicating the presence of a higher NO bioavailability
in hearts treated with BE compared to untreated hearts.
Therefore, these data are strong arguments to justify the
involvement of NO in the attenuation of postischemic
myocardial dysfunction afforded by the extract.
This study clearly demonstrates for the first time the
protective effect of a nonalcoholic extract of berry fruit from
Vaccinium meridionale against reperfusion injury in isolated
rat heart. These cardioprotective properties may be linked
to the ability of the extract to induce eNOS expression via
Akt and to scavenge ROS. From these results, we propose
that the “mortin˜o” extract could be a promising therapeutic
approach against myocardial dysfunction. Moreover, being
the fermented extract of berry fruit a source of polyphenols,
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Figure 6: (a) Representative Western blots and mean data of eNOS; (b) phospho-Akt (p-Akt) protein expression normalized to GAPDH in
ischemic control hearts (IC, 𝑛 = 6) and in hearts treated with both fermented berry extract (BE, 𝑛 = 6) and berry juice (BJ, 𝑛 = 6) and BE
+ L-NAME (𝑛 = 4). It is observed that only BE increased the expression of eNOS and p-Akt and this increase was abolished when NOS was
inhibited with L-NAME. ∗𝑃 < 0.05 with respect to IC; #𝑃 < 0.05 with respect to BE.
it could be used as a functional food to prevent or mitigate
pathologies associated to oxidative stress [48].
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